PortfoliosLab logo
ALPN vs. RXST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ALPN and RXST is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

ALPN vs. RXST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alpine Immune Sciences, Inc. (ALPN) and RxSight, Inc. (RXST). The values are adjusted to include any dividend payments, if applicable.

0.00%100.00%200.00%300.00%400.00%500.00%600.00%December2025FebruaryMarchAprilMay
634.95%
-6.88%
ALPN
RXST

Key characteristics

Fundamentals

Market Cap

ALPN:

$4.46B

RXST:

$643.83M

EPS

ALPN:

-$0.64

RXST:

-$0.71

PS Ratio

ALPN:

71.68

RXST:

4.60

PB Ratio

ALPN:

12.87

RXST:

2.29

Returns By Period


ALPN

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

RXST

YTD

-56.66%

1M

-10.30%

6M

-72.78%

1Y

-76.04%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ALPN vs. RXST — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALPN
The Risk-Adjusted Performance Rank of ALPN is 5353
Overall Rank
The Sharpe Ratio Rank of ALPN is 3838
Sharpe Ratio Rank
The Sortino Ratio Rank of ALPN is 7070
Sortino Ratio Rank
The Omega Ratio Rank of ALPN is 9090
Omega Ratio Rank
The Calmar Ratio Rank of ALPN is 3131
Calmar Ratio Rank
The Martin Ratio Rank of ALPN is 3434
Martin Ratio Rank

RXST
The Risk-Adjusted Performance Rank of RXST is 22
Overall Rank
The Sharpe Ratio Rank of RXST is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of RXST is 22
Sortino Ratio Rank
The Omega Ratio Rank of RXST is 22
Omega Ratio Rank
The Calmar Ratio Rank of RXST is 11
Calmar Ratio Rank
The Martin Ratio Rank of RXST is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ALPN vs. RXST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Alpine Immune Sciences, Inc. (ALPN) and RxSight, Inc. (RXST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Rolling 12-month Sharpe Ratio-2.000.002.004.006.008.00December2025FebruaryMarchAprilMay
1.83
-1.22
ALPN
RXST

Dividends

ALPN vs. RXST - Dividend Comparison

Neither ALPN nor RXST has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ALPN vs. RXST - Drawdown Comparison


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-0.00%
-76.82%
ALPN
RXST

Volatility

ALPN vs. RXST - Volatility Comparison

The current volatility for Alpine Immune Sciences, Inc. (ALPN) is 0.00%, while RxSight, Inc. (RXST) has a volatility of 20.84%. This indicates that ALPN experiences smaller price fluctuations and is considered to be less risky than RXST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%December2025FebruaryMarchAprilMay0
20.84%
ALPN
RXST

Financials

ALPN vs. RXST - Financials Comparison

This section allows you to compare key financial metrics between Alpine Immune Sciences, Inc. and RxSight, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M50.00MAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
7.03M
40.21M
(ALPN) Total Revenue
(RXST) Total Revenue
Values in USD except per share items